Back to Results
First PageMeta Content
Pharmaceutical industry / Clinical research / Pharmacology / Food and Drug Administration / Dissolution testing / IVIVC / Pharmaceutical sciences / In vivo / In vitro


Biorelevant In-Vitro Release Testing of NonOral Dosage Forms – FDA Perspectives Tapash Ghosh, Ph.D Team Leader, Biopharmaceutics, ONDQA, FDA Annual AAPS, San Antonio, Texas November 11, 2013 Disclaimer: The contents of
Add to Reading List

Open Document

File Size: 405,20 KB

Share Result on Facebook
UPDATE